Brief: Geneuro H1 net loss widens to 8.0 millon euros

Geneuro SA

28/09/2017 17:02

Sept 28 (Reuters) - Geneuro SA  GNRO.PA : 
    * CASH POSITION OF EUR 23.1 MILLION AS OF JUNE 30, 2017 
    * FINAL RESULTS FROM FULL 12-MONTH STUDY  OF CHANGE-MS PHASE 
2B CLINICAL TRIAL IN MULTIPLE SCLEROSIS ARE EXPECTED IN Q12018 
    * H1 NET LOSS FOR THE PERIOD EUR 8.0 MILLION VERSUS RESTATED 
LOSS FOR THE PERIOD OF EUR 6.0 MILLION YEAR AGO 
    * CHANGE-MS PHASE 2B CLINICAL TRIAL IN MULTIPLE SCLEROSIS 
FINAL ARE EXPECTED IN Q12018 
 
Source text for Eikon:  ID:nBw5lV3Gca  
Further company coverage:  GNRO.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))